Trump Drops a Flurry of Nominees to Head FDA, OMB, CDC, and HUD
We Might Have a Problem With Trump's Labor Secretary Nominee
Trump Makes His Pick for Treasury Secretary
The Press Delivers a Fake News Trump Health Crisis, and the Bad Week...
Wisdom From the Founders: Madison and 'Gradual and Silent Encroachments'
CFPB Director Exemplifies the Worst of Washington Hypocrisy
Trump Victory: From Neocons to Americons
It’s Time to Make Healthcare Great Again
Deportation Is Necessary to Undo Harm Done at the Border
Do You Know Where the Migrant Children Are? Why States Can't Wait for...
Biden’s Union-Based Concerns Undercut U.S. Security and Jeopardize Steel Production
Joy Reid Spews Hate Toward Trump Supporters Once Again
America's National Debt Just Hit a New Record
The View Forced to Read Three Legal Notes Within Minutes of One Another...
Watch This ABC Reporter Goes on Massive Tangent Blaming Trump for Laken Riley's...
Tipsheet

FDA Authorizes Pfizer, Moderna Booster Shots for All American Adults

AP Photo/Matt Rourke

The Food and Drug Administration (FDA) authorized Wuhan coronavirus booster shots for all U.S. adults, the Administration shared in an announcement on Friday. 

Advertisement

All U.S. residents over the age of 18 will be eligible to receive a booster of the Pfizer-BioNTech or Moderna vaccine. The announcement notes that the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices will convene today to discuss further clinical recommendations. 

“Throughout the course of the COVID-19 pandemic, the FDA has worked to make timely public health decisions as the pandemic evolves. COVID-19 vaccines have proven to be the best and highly effective defense against COVID-19. Authorizing the use of a single booster dose of either the Moderna or Pfizer-BioNTech COVID-19 vaccine for individuals 18 years of age and older helps to provide continued protection against COVID-19, including the serious consequences that can occur, such as hospitalization and death,” said Acting FDA Commissioner Janet Woodcock in a statement. 

As we covered, the FDA previously authorized boosters for individuals 65 years of age and older, and those at “high risk” of severe COVID-19. Now, all adults can get a booster at least six months after the primary two-dose vaccination series of Pfizer or Moderna. 

Advertisement

“The FDA has determined that the currently available data support expanding the eligibility of a single booster dose of the Moderna and Pfizer-BioNTech COVID-19 vaccines to individuals 18 years of age and older,” said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, in a statement. “Streamlining the eligibility criteria and making booster doses available to all individuals 18 years of age and older will also help to eliminate confusion about who may receive a booster dose and ensure booster doses are available to all who may need one.” 

Furthermore, the FDA will allow booster shot recipients to “mix and match” which brand they receive for their primary dosage and booster shot dose. For example, recipients of the Pfizer two-dose COVID-19 vaccine could opt for the Moderna booster shot if they choose. 

The announcement notes that post-authorization, post-marketing studies are being conducted to “assess known serious risks of myocarditis and pericarditis.” Additionally, both the FDA and CDC have “several systems in place to continually monitor COVID-19 vaccine safety and allow for the rapid detection and investigation of potential safety concerns.”

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement